category	term	number_of_genes	number_of_genes_in_background	ncbiTaxonId	inputGenes	preferredNames	p_value	fdr	description
COMPARTMENTS	GOCC:0005622	33	11202	9606	CLDN11,OAS3,GMPR,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,CLUH,RNF213,BCL2L13	CLDN11,OAS3,GMPR,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,CLUH,RNF213,BCL2L13	6.5e-06	0.015	Intracellular
COMPARTMENTS	GOCC:0043226	31	9848	9606	CLDN11,OAS3,CD97,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	CLDN11,OAS3,CD97,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	7.82e-06	0.015	Organelle
COMPARTMENTS	GOCC:0043227	29	8685	9606	OAS3,CD97,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,CETN2,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	OAS3,CD97,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,CETN2,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	1.01e-05	0.015	Membrane-bounded organelle
COMPARTMENTS	GOCC:0043229	30	9242	9606	CLDN11,OAS3,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	CLDN11,OAS3,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	8.68e-06	0.015	Intracellular organelle
COMPARTMENTS	GOCC:0043231	26	7476	9606	OAS3,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,CETN2,IFIT3,IFIT2,RCC1,TAP2,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	OAS3,SPAG9,SAMHD1,SNRNP40,NSUN5,MX2,OAS2,DARS2,CETN2,IFIT3,IFIT2,RCC1,TAP2,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,RNF213,BCL2L13	3.69e-05	0.017	Intracellular membrane-bounded organelle
COMPARTMENTS	GOCC:0098844	2	5	9606	MX2,MX1	MX2,MX1	6.85e-05	0.0247	Postsynaptic endocytic zone membrane
COMPARTMENTS	GOCC:0110165	35	13853	9606	CLDN11,OAS3,CD97,NECTIN2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,CLUH,RNF213,BCL2L13	CLDN11,OAS3,CD97,PVRL2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,CLUH,RNF213,BCL2L13	6.4e-05	0.0247	Cellular anatomical entity
COMPARTMENTS	GOCC:0005737	26	7871	9606	CLDN11,OAS3,SPAG9,MX2,OAS2,DARS2,RAB4A,GNAI3,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,EBP,GOLIM4,LAMTOR3,CLUH,RNF213,BCL2L13	CLDN11,OAS3,SPAG9,MX2,OAS2,DARS2,RAB4A,GNAI3,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,EBP,GOLIM4,LAMTOR3,CLUH,RNF213,BCL2L13	0.0001	0.0298	Cytoplasm
COMPARTMENTS	GOCC:0030670	3	48	9606	TAP2,HLA-A,HLA-B	TAP2,HLA-A,HLA-B	0.00011	0.0298	Phagocytic vesicle membrane
COMPARTMENTS	GOCC:0044327	2	7	9606	MX2,MX1	MX2,MX1	0.00012	0.0298	Dendritic spine head
COMPARTMENTS	GOCC:0042612	2	8	9606	HLA-A,HLA-B	HLA-A,HLA-B	0.00015	0.0307	MHC class I protein complex
COMPARTMENTS	GOCC:0042824	2	9	9606	TAP2,HLA-A	TAP2,HLA-A	0.00018	0.0344	MHC class I peptide loading complex
COMPARTMENTS	GOCC:0005635	5	296	9606	MX2,CETN2,RCC1,MX1,EBP	MX2,CETN2,RCC1,MX1,EBP	0.00021	0.0348	Nuclear envelope
Process	GO:0060337	10	67	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	1.12e-16	1.43e-12	Type i interferon signaling pathway
Process	GO:0051607	9	210	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.67e-10	5.36e-07	Defense response to virus
Process	GO:0002252	13	969	9606	OAS3,CD97,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3	OAS3,CD97,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3	9.12e-09	1.95e-05	Immune effector process
Process	GO:0045087	11	703	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	3.63e-08	6.66e-05	Innate immune response
Process	GO:0006955	14	1588	9606	OAS3,CD97,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3	OAS3,CD97,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3	3.81e-07	0.00054	Immune response
Process	GO:0044419	15	1899	9606	OAS3,NECTIN2,SAMHD1,FBLN1,MX2,OAS2,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,HLA-A,MX1,HLA-B	OAS3,PVRL2,SAMHD1,FBLN1,MX2,OAS2,IFIT1,IFIT3,IFIT2,RCC1,TAP2,DDX58,HLA-A,MX1,HLA-B	5.05e-07	0.00059	Interspecies interaction between organisms
Process	GO:0071345	11	1013	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B,PNPT1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B,PNPT1	1.35e-06	0.0014	Cellular response to cytokine stimulus
Process	GO:0019885	3	10	9606	TAP2,HLA-A,HLA-B	TAP2,HLA-A,HLA-B	1.61e-06	0.0016	Antigen processing and presentation of endogenous peptide antigen via mhc class i
Process	GO:0048525	5	105	9606	OAS3,FBLN1,OAS2,IFIT1,MX1	OAS3,FBLN1,OAS2,IFIT1,MX1	1.67e-06	0.0016	Negative regulation of viral process
Process	GO:0006952	12	1296	9606	OAS3,CD97,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	OAS3,CD97,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	2.06e-06	0.0018	Defense response
Process	GO:0050792	6	215	9606	OAS3,NECTIN2,FBLN1,OAS2,IFIT1,MX1	OAS3,PVRL2,FBLN1,OAS2,IFIT1,MX1	2.82e-06	0.0023	Regulation of viral process
Process	GO:0045071	4	61	9606	OAS3,OAS2,IFIT1,MX1	OAS3,OAS2,IFIT1,MX1	5.99e-06	0.0038	Negative regulation of viral genome replication
Process	GO:0061025	5	136	9606	NECTIN2,MX2,GNAI3,TAP2,MX1	PVRL2,MX2,GNAI3,TAP2,MX1	5.65e-06	0.0038	Membrane fusion
Process	GO:0016032	9	776	9606	NECTIN2,SAMHD1,FBLN1,IFIT1,RCC1,TAP2,DDX58,HLA-A,HLA-B	PVRL2,SAMHD1,FBLN1,IFIT1,RCC1,TAP2,DDX58,HLA-A,HLA-B	9e-06	0.0053	Viral process
Process	GO:0060333	4	70	9606	OAS3,OAS2,HLA-A,HLA-B	OAS3,OAS2,HLA-A,HLA-B	1.01e-05	0.0055	Interferon-gamma-mediated signaling pathway
Process	GO:1903900	5	153	9606	OAS3,NECTIN2,OAS2,IFIT1,MX1	OAS3,PVRL2,OAS2,IFIT1,MX1	9.84e-06	0.0055	Regulation of viral life cycle
Process	GO:0002376	15	2481	9606	OAS3,CD97,SAMHD1,MX2,OAS2,RAB4A,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3	OAS3,CD97,SAMHD1,MX2,OAS2,RAB4A,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3	1.44e-05	0.0066	Immune system process
Process	GO:0035455	3	23	9606	MX2,IFIT3,IFIT2	MX2,IFIT3,IFIT2	1.44e-05	0.0066	Response to interferon-alpha
Process	GO:0001916	3	25	9606	NECTIN2,HLA-A,HLA-B	PVRL2,HLA-A,HLA-B	1.81e-05	0.0077	Positive regulation of t cell mediated cytotoxicity
Process	GO:0002486	2	3	9606	HLA-A,HLA-B	HLA-A,HLA-B	3.27e-05	0.0124	Antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway, tap-independent
Process	GO:0071310	14	2369	9606	OAS3,SAMHD1,MX2,OAS2,GNAI3,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B,PNPT1,LAMTOR3	OAS3,SAMHD1,MX2,OAS2,GNAI3,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B,PNPT1,LAMTOR3	4.12e-05	0.0139	Cellular response to organic substance
Process	GO:0006950	17	3485	9606	OAS3,CD97,GMPR,SPAG9,SAMHD1,FBLN1,MX2,OAS2,CETN2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B,PNPT1	OAS3,CD97,GMPR,SPAG9,SAMHD1,FBLN1,MX2,OAS2,CETN2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B,PNPT1	4.97e-05	0.0164	Response to stress
Process	GO:0042269	3	41	9606	NECTIN2,HLA-A,HLA-B	PVRL2,HLA-A,HLA-B	7.15e-05	0.023	Regulation of natural killer cell mediated cytotoxicity
Process	GO:0002831	6	406	9606	NECTIN2,SAMHD1,IFIT1,DDX58,HLA-A,HLA-B	PVRL2,SAMHD1,IFIT1,DDX58,HLA-A,HLA-B	9.49e-05	0.0286	Regulation of response to biotic stimulus
Process	GO:0042270	2	6	9606	HLA-A,HLA-B	HLA-A,HLA-B	9.12e-05	0.0286	Protection from natural killer cell mediated cytotoxicity
Process	GO:0016185	2	7	9606	MX2,MX1	MX2,MX1	0.00012	0.0334	Synaptic vesicle budding from presynaptic endocytic zone membrane
Process	GO:0002705	4	137	9606	NECTIN2,DDX58,HLA-A,HLA-B	PVRL2,DDX58,HLA-A,HLA-B	0.00013	0.0349	Positive regulation of leukocyte mediated immunity
Process	GO:0002480	2	8	9606	HLA-A,HLA-B	HLA-A,HLA-B	0.00015	0.0391	Antigen processing and presentation of exogenous peptide antigen via mhc class i, tap-independent
Process	GO:0098884	2	8	9606	MX2,MX1	MX2,MX1	0.00015	0.0391	Postsynaptic neurotransmitter receptor internalization
Process	GO:0007005	6	452	9606	NECTIN2,MX2,IFIT2,MX1,PNPT1,CLUH	PVRL2,MX2,IFIT2,MX1,PNPT1,CLUH	0.00017	0.0426	Mitochondrion organization
Process	GO:0060700	2	9	9606	OAS3,OAS2	OAS3,OAS2	0.00018	0.0441	Regulation of ribonuclease activity
Function	GO:0003723	15	1649	9606	OAS3,SAMHD1,SNRNP40,NSUN5,OAS2,DARS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,PNPT1,ZC3H18,HELZ2,CLUH	OAS3,SAMHD1,SNRNP40,NSUN5,OAS2,DARS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,PNPT1,ZC3H18,HELZ2,CLUH	8.05e-08	0.00026	RNA binding
Function	GO:0046977	3	7	9606	TAP2,HLA-A,HLA-B	TAP2,HLA-A,HLA-B	6.77e-07	0.0011	TAP binding
Function	GO:0001730	2	3	9606	OAS3,OAS2	OAS3,OAS2	3.27e-05	0.0353	2-5-oligoadenylate synthetase activity
Function	GO:0017111	8	760	9606	MX2,RAB4A,GNAI3,TAP2,DDX58,MX1,HELZ2,RNF213	MX2,RAB4A,GNAI3,TAP2,DDX58,MX1,HELZ2,RNF213	6.11e-05	0.0494	Nucleoside-triphosphatase activity
Function	GO:0140098	6	375	9606	SAMHD1,NSUN5,DARS2,DDX58,PNPT1,HELZ2	SAMHD1,NSUN5,DARS2,DDX58,PNPT1,HELZ2	6.17e-05	0.0494	Catalytic activity, acting on rna
TISSUES	BTO:0000081	26	6107	9606	CLDN11,CD97,NECTIN2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,RCC1,DDX58,HLA-A,MX1,HLA-B,PNPT1,ZC3H18,EBP,CLUH,RNF213,BCL2L13	CLDN11,CD97,PVRL2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,RCC1,DDX58,HLA-A,MX1,HLA-B,PNPT1,ZC3H18,EBP,CLUH,RNF213,BCL2L13	5.28e-07	0.001	Reproductive system
TISSUES	BTO:0003091	27	6716	9606	CLDN11,CD97,NECTIN2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,RCC1,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,ZC3H18,EBP,CLUH,RNF213,BCL2L13	CLDN11,CD97,PVRL2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,RCC1,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,ZC3H18,EBP,CLUH,RNF213,BCL2L13	7.59e-07	0.001	Urogenital system
TISSUES	BTO:0000083	23	5799	9606	CLDN11,CD97,NECTIN2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,OAS2,DARS2,RAB4A,GNAI3,CETN2,RCC1,DDX58,HLA-A,MX1,HLA-B,PNPT1,ZC3H18,CLUH,RNF213,BCL2L13	CLDN11,CD97,PVRL2,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,OAS2,DARS2,RAB4A,GNAI3,CETN2,RCC1,DDX58,HLA-A,MX1,HLA-B,PNPT1,ZC3H18,CLUH,RNF213,BCL2L13	2.23e-05	0.0142	Female reproductive system
TISSUES	BTO:0001489	34	12619	9606	CLDN11,OAS3,CD97,NECTIN2,GMPR,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,RCC1,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPART,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,CLUH,RNF213,BCL2L13	CLDN11,OAS3,CD97,PVRL2,GMPR,SPAG9,SAMHD1,SNRNP40,NSUN5,FBLN1,MX2,OAS2,DARS2,RAB4A,GNAI3,CETN2,IFIT1,IFIT3,RCC1,DDX58,IDI1,HLA-A,MX1,HLA-B,PNPT1,SPG20,ZC3H18,EBP,GOLIM4,HELZ2,LAMTOR3,CLUH,RNF213,BCL2L13	2.98e-05	0.0142	Whole body
DISEASES	DOID:0060861	4	8	9606	OAS3,OAS2,DDX58,MX1	OAS3,OAS2,DDX58,MX1	4.69e-09	2.05e-05	Microphthalmia with limb anomalies
Keyword	KW-0051	9	127	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	2.29e-12	1.55e-09	Antiviral defense
Keyword	KW-0399	11	324	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	1.27e-11	4.28e-09	Innate immunity
Keyword	KW-0391	12	522	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B	1.02e-10	2.3e-08	Immunity
Keyword	KW-0945	8	534	9606	NECTIN2,SAMHD1,FBLN1,IFIT1,TAP2,DDX58,HLA-A,HLA-B	PVRL2,SAMHD1,FBLN1,IFIT1,TAP2,DDX58,HLA-A,HLA-B	4.96e-06	0.00084	Host-virus interaction
Keyword	KW-0694	8	670	9606	OAS3,NSUN5,OAS2,IFIT1,IFIT2,DDX58,PNPT1,CLUH	OAS3,NSUN5,OAS2,IFIT1,IFIT2,DDX58,PNPT1,CLUH	2.52e-05	0.0034	RNA-binding
Keyword	KW-0490	2	8	9606	HLA-A,HLA-B	HLA-A,HLA-B	0.00015	0.0165	MHC I
Keyword	KW-0547	11	1760	9606	OAS3,SAMHD1,MX2,OAS2,DARS2,RAB4A,GNAI3,TAP2,DDX58,MX1,HELZ2	OAS3,SAMHD1,MX2,OAS2,DARS2,RAB4A,GNAI3,TAP2,DDX58,MX1,HELZ2	0.00023	0.0219	Nucleotide-binding
Keyword	KW-0802	4	161	9606	IFIT1,IFIT3,IFIT2,CLUH	IFIT1,IFIT3,IFIT2,CLUH	0.00023	0.0219	TPR repeat
Keyword	KW-0548	3	69	9606	OAS3,OAS2,PNPT1	OAS3,OAS2,PNPT1	0.00031	0.0234	Nucleotidyltransferase
Keyword	KW-0342	5	337	9606	SAMHD1,MX2,RAB4A,GNAI3,MX1	SAMHD1,MX2,RAB4A,GNAI3,MX1	0.00038	0.0257	GTP-binding
Keyword	KW-0007	15	3341	9606	OAS3,SPAG9,SAMHD1,NSUN5,OAS2,DARS2,CETN2,IFIT2,DDX58,IDI1,MX1,PNPT1,SPART,ZC3H18,EBP	OAS3,SPAG9,SAMHD1,NSUN5,OAS2,DARS2,CETN2,IFIT2,DDX58,IDI1,MX1,PNPT1,SPG20,ZC3H18,EBP	0.00046	0.0282	Acetylation
Keyword	KW-0152	2	20	9606	IDI1,EBP	IDI1,EBP	0.00074	0.0417	Cholesterol biosynthesis
KEGG	hsa05160	7	156	9606	CLDN11,OAS3,MX2,OAS2,IFIT1,DDX58,MX1	CLDN11,OAS3,MX2,OAS2,IFIT1,DDX58,MX1	1.65e-08	5.53e-06	Hepatitis C
KEGG	hsa05169	6	193	9606	OAS3,OAS2,TAP2,DDX58,HLA-A,HLA-B	OAS3,OAS2,TAP2,DDX58,HLA-A,HLA-B	1.53e-06	0.00026	Epstein-Barr virus infection
KEGG	hsa05162	5	138	9606	OAS3,MX2,OAS2,DDX58,MX1	OAS3,MX2,OAS2,DDX58,MX1	6.05e-06	0.00068	Measles
KEGG	hsa05164	5	165	9606	OAS3,MX2,OAS2,DDX58,MX1	OAS3,MX2,OAS2,DDX58,MX1	1.4e-05	0.0012	Influenza A
KEGG	hsa05170	5	204	9606	SAMHD1,GNAI3,TAP2,HLA-A,HLA-B	SAMHD1,GNAI3,TAP2,HLA-A,HLA-B	3.78e-05	0.0025	Human immunodeficiency virus 1 infection
KEGG	hsa04514	4	137	9606	CLDN11,NECTIN2,HLA-A,HLA-B	CLDN11,PVRL2,HLA-A,HLA-B	0.00013	0.0071	Cell adhesion molecules
KEGG	hsa04612	3	63	9606	TAP2,HLA-A,HLA-B	TAP2,HLA-A,HLA-B	0.00024	0.0111	Antigen processing and presentation
KEGG	hsa05168	6	479	9606	OAS3,OAS2,TAP2,DDX58,HLA-A,HLA-B	OAS3,OAS2,TAP2,DDX58,HLA-A,HLA-B	0.00023	0.0111	Herpes simplex virus 1 infection
KEGG	hsa05163	4	218	9606	GNAI3,TAP2,HLA-A,HLA-B	GNAI3,TAP2,HLA-A,HLA-B	0.00071	0.0265	Human cytomegalovirus infection
KEGG	hsa04144	4	241	9606	RAB4A,HLA-A,HLA-B,SPART	RAB4A,HLA-A,HLA-B,SPG20	0.001	0.0344	Endocytosis
PMID	PMID:34771433	11	38	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B,RNF213	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B,RNF213	4.08e-21	1.61e-14	(2021) Multi-Omics Analysis of Glioblastoma Cells Sensitivity to Oncolytic Viruses.
PMID	PMID:30496325	9	34	9606	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	4.33e-17	8.54e-11	(2018) Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity.
PMID	PMID:35235083	8	20	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.7e-16	2.23e-10	(2022) Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
PMID	PMID:22694362	9	44	9606	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B	3.36e-16	3.32e-10	(2012) Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study.
PMID	PMID:29264452	9	51	9606	OAS3,SAMHD1,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	OAS3,SAMHD1,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	1.11e-15	8.77e-10	(2017) Coxsackievirus-Induced Proteomic Alterations in Primary Human Islets Provide Insights for the Etiology of Diabetes.
PMID	PMID:30959732	7	12	9606	OAS3,SAMHD1,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.88e-15	1.24e-09	(2019) SAMHD1 Enhances Chikungunya and Zika Virus Replication in Human Skin Fibroblasts.
PMID	PMID:28806913	8	31	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	3.32e-15	1.87e-09	(2017) Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.
PMID	PMID:34982558	8	32	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	4.14e-15	2.04e-09	(2022) Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV.
PMID	PMID:34992733	8	33	9606	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,HLA-A,MX1	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,HLA-A,MX1	5.14e-15	2.04e-09	(2022) Global proteomics of fibroblast cells treated with bacterial cyclic dinucleotides, c-di-GMP and c-di-AMP.
PMID	PMID:28106799	8	32	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	4.14e-15	2.04e-09	(2017) RNA Editing, ADAR1, and the Innate Immune Response.
PMID	PMID:34552595	9	65	9606	OAS3,MX2,OAS2,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	OAS3,MX2,OAS2,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	8.17e-15	2.93e-09	(2021) Tissue-Resident-Memory CD8(+) T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.
PMID	PMID:34160465	8	36	9606	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	9.49e-15	3.12e-09	(2021) Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis.
PMID	PMID:25902143	8	39	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	1.68e-14	5.09e-09	(2015) Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
PMID	PMID:21886832	8	39	9606	CD97,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B	CD97,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B	1.68e-14	5.09e-09	(2011) Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse.
PMID	PMID:34372578	10	120	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HELZ2	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HELZ2	2.54e-14	6.69e-09	(2021) Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
PMID	PMID:31665046	9	76	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HELZ2	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HELZ2	3e-14	7.03e-09	(2019) Identifying novel biomarkers of the pediatric influenza infection by weighted co-expression network analysis.
PMID	PMID:24713352	8	42	9606	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	2.85e-14	7.03e-09	(2014) Interferon-stimulated genes: roles in viral pathogenesis.
PMID	PMID:25170834	8	45	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	4.69e-14	1.03e-08	(2014) HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.
PMID	PMID:30949159	10	130	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1	5.41e-14	1.12e-08	(2019) Single-Cell Transcriptome Analysis of CD34(+) Stem Cell-Derived Myeloid Cells Infected With Human Cytomegalovirus.
PMID	PMID:33335862	8	49	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	8.7e-14	1.72e-08	(2020) Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?
PMID	PMID:34876791	7	24	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	9.65e-14	1.81e-08	(2021) Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients.
PMID	PMID:34880855	7	24	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	9.65e-14	1.81e-08	(2021) Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
PMID	PMID:34490145	8	52	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.34e-13	2.3e-08	(2021) Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling.
PMID	PMID:29215570	8	53	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.54e-13	2.45e-08	(2017) Host Cell Restriction Factors that Limit Influenza A Infection.
PMID	PMID:27479908	9	92	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	1.49e-13	2.45e-08	(2016) Tensor decomposition for multiple-tissue gene expression experiments.
PMID	PMID:28959263	8	54	9606	SAMHD1,MX2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	SAMHD1,MX2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	1.77e-13	2.69e-08	(2017) Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression.
PMID	PMID:31465999	8	57	9606	OAS3,SAMHD1,MX2,IFIT1,IFIT3,DDX58,MX1,RNF213	OAS3,SAMHD1,MX2,IFIT1,IFIT3,DDX58,MX1,RNF213	2.63e-13	3.85e-08	(2019) Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii.
PMID	PMID:24065129	7	29	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	3.05e-13	4.29e-08	(2013) IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
PMID	PMID:33450175	8	59	9606	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	3.39e-13	4.61e-08	(2021) Evolutionary conflicts and adverse effects of antiviral factors.
PMID	PMID:24528865	7	30	9606	OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B	OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,HLA-B	3.75e-13	4.93e-08	(2014) Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
PMID	PMID:33770145	7	31	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	4.59e-13	5.75e-08	(2021) The herpesvirus accessory protein gamma134.5 facilitates viral replication by disabling mitochondrial translocation of RIG-I.
PMID	PMID:31653097	6	12	9606	MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	4.52e-13	5.75e-08	(2019) Special Issue IFN-Independent ISG Expression and its Role in Antiviral Cell-Intrinsic Innate Immunity.
PMID	PMID:31886250	6	12	9606	OAS3,MX2,OAS2,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT3,IFIT2,MX1	4.52e-13	5.75e-08	(2019) Identification of Potential Biomarkers and Biological Pathways in Juvenile Dermatomyositis Based on miRNA-mRNA Network.
PMID	PMID:30400182	8	62	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	4.89e-13	5.75e-08	(2018) Transcriptomics Reveal Antiviral Gene Induction in the Egyptian Rousette Bat Is Antagonized In Vitro by Marburg Virus Infection.
PMID	PMID:33968942	8	64	9606	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	6.18e-13	6.97e-08	(2021) Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.
PMID	PMID:27434537	8	64	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	6.18e-13	6.97e-08	(2016) Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling.
PMID	PMID:34140575	7	34	9606	OAS3,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	8.15e-13	8.69e-08	(2021) Remodeling of bronchial epithelium caused by asthmatic inflammation affects its response to rhinovirus infection.
PMID	PMID:31937643	7	35	9606	OAS3,MX2,OAS2,IFIT1,DDX58,MX1,RNF213	OAS3,MX2,OAS2,IFIT1,DDX58,MX1,RNF213	9.76e-13	1.01e-07	(2020) Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.
PMID	PMID:32164778	7	37	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	1.38e-12	1.4e-07	(2020) Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
PMID	PMID:33142113	8	72	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.48e-12	1.46e-07	(2020) Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
PMID	PMID:30804934	7	38	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.64e-12	1.57e-07	(2019) The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
PMID	PMID:33290632	7	40	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	2.26e-12	2.12e-07	(2021) G-quadruplex-forming nucleic acids interact with splicing factor 3B subunit 2 and suppress innate immune gene expression.
PMID	PMID:31611566	7	40	9606	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	2.26e-12	2.12e-07	(2019) Experimental challenge with bovine respiratory syncytial virus in dairy calves: bronchial lymph node transcriptome response.
PMID	PMID:30775418	7	41	9606	MX2,OAS2,IFIT2,DDX58,HLA-A,MX1,HLA-B	MX2,OAS2,IFIT2,DDX58,HLA-A,MX1,HLA-B	2.64e-12	2.37e-07	(2019) Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma.
PMID	PMID:24614210	7	41	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	2.64e-12	2.37e-07	(2014) E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-kappa transcription in keratinocytes.
PMID	PMID:34340653	7	42	9606	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	3.08e-12	2.64e-07	(2021) Stage-specific transcriptomic changes in pancreatic alpha-cells after massive beta-cell loss.
PMID	PMID:31641281	7	42	9606	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,MX1	3.08e-12	2.64e-07	(2020) A clinical score to guide in decision making for monogenic type I IFNopathies.
PMID	PMID:33922087	8	80	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1,HLA-B	OAS3,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1,HLA-B	3.25e-12	2.67e-07	(2021) Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.
PMID	PMID:34818375	6	19	9606	OAS3,MX2,OAS2,IFIT3,DDX58,MX1	OAS3,MX2,OAS2,IFIT3,DDX58,MX1	4.27e-12	3.33e-07	(2021) Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis.
PMID	PMID:29526487	7	44	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	4.14e-12	3.33e-07	(2018) Innate Antiviral Immunity in the Skin.
PMID	PMID:26998760	6	19	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	4.27e-12	3.33e-07	(2016) Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses.
PMID	PMID:22906315	7	44	9606	OAS3,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	4.14e-12	3.33e-07	(2012) Chemoattraction of macrophages by secretory molecules derived from cells expressing the signal peptide of eosinophil cationic protein.
PMID	PMID:20931559	6	19	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	4.27e-12	3.33e-07	(2010) IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
PMID	PMID:18648529	8	83	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	4.29e-12	3.33e-07	(2008) Type I interferon: potential therapeutic target for psoriasis?
PMID	PMID:32901521	7	46	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	5.5e-12	3.95e-07	(2020) Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells.
PMID	PMID:33147460	8	86	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1,RNF213	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1,RNF213	5.59e-12	3.95e-07	(2020) Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection.
PMID	PMID:33276587	7	48	9606	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	7.22e-12	5e-07	(2020) Host Cell Restriction Factors of Paramyxoviruses and Pneumoviruses.
PMID	PMID:35028607	7	49	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	8.24e-12	5.61e-07	(2021) Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children.
PMID	PMID:34079533	6	22	9606	SAMHD1,IFIT1,IFIT3,DDX58,MX1,HLA-B	SAMHD1,IFIT1,IFIT3,DDX58,MX1,HLA-B	9.06e-12	6.06e-07	(2021) Paracrine IFN Response Limits ZIKV Infection in Human Sertoli Cells.
PMID	PMID:34180358	6	22	9606	OAS3,OAS2,IFIT1,IFIT3,DDX58,MX1	OAS3,OAS2,IFIT1,IFIT3,DDX58,MX1	9.06e-12	6.06e-07	(2021) Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis.
PMID	PMID:28805681	8	92	9606	OAS3,GMPR,MX2,OAS2,IFIT1,DDX58,MX1,HELZ2	OAS3,GMPR,MX2,OAS2,IFIT1,DDX58,MX1,HELZ2	9.28e-12	6.06e-07	(2017) Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
PMID	PMID:29253856	7	50	9606	SAMHD1,OAS2,IFIT2,DDX58,HLA-A,MX1,RNF213	SAMHD1,OAS2,IFIT2,DDX58,HLA-A,MX1,RNF213	9.39e-12	6.06e-07	(2017) Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses.
PMID	PMID:32508817	7	51	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	1.07e-11	6.68e-07	(2020) Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection.
PMID	PMID:23781071	7	51	9606	SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.07e-11	6.68e-07	(2013) A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response.
PMID	PMID:35422859	6	24	9606	MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	1.42e-11	8.29e-07	(2022) Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19.
PMID	PMID:34188173	7	53	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,DDX58,MX1	1.37e-11	8.29e-07	(2021) SCD2-mediated monounsaturated fatty acid metabolism regulates cGAS-STING-dependent type I IFN responses in CD4(+) T cells.
PMID	PMID:34522293	6	24	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	1.42e-11	8.29e-07	(2021) Making use of transcription factor enrichment to identify functional microRNA-regulons.
PMID	PMID:34857786	8	99	9606	SAMHD1,MX2,OAS2,IFIT1,IFIT3,HLA-A,MX1,HLA-B	SAMHD1,MX2,OAS2,IFIT1,IFIT3,HLA-A,MX1,HLA-B	1.61e-11	8.29e-07	(2021) Integrative epigenomics in Sjoegrens syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.
PMID	PMID:34900733	7	53	9606	OAS3,OAS2,IFIT1,IFIT2,DDX58,MX1,PNPT1	OAS3,OAS2,IFIT1,IFIT2,DDX58,MX1,PNPT1	1.37e-11	8.29e-07	(2021) Hypoxia Regulates Endogenous Double-Stranded RNA Production via Reduced Mitochondrial DNA Transcription.
PMID	PMID:30871003	6	24	9606	MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.42e-11	8.29e-07	(2019) Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression.
PMID	PMID:31200452	7	53	9606	OAS3,GMPR,MX2,IFIT1,IFIT3,IFIT2,MX1	OAS3,GMPR,MX2,IFIT1,IFIT3,IFIT2,MX1	1.37e-11	8.29e-07	(2019) Altered Gene Expression in Dioxin-Like and Non-Dioxin-Like PCB Exposed Peripheral Blood Mononuclear Cells.
PMID	PMID:31658769	6	24	9606	MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	MX2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.42e-11	8.29e-07	(2019) Whole Transcriptome Analyses Reveal Differential mRNA and microRNA Expression Profiles in Primary Human Dermal Fibroblasts Infected with Clinical or Vaccine Strains of Varicella Zoster Virus.
PMID	PMID:30471916	7	54	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.54e-11	8.29e-07	(2018) Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.
PMID	PMID:28215278	7	53	9606	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58	1.37e-11	8.29e-07	(2017) Nucleic Acid Immunity.
PMID	PMID:28786993	6	24	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2	1.42e-11	8.29e-07	(2017) A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study.
PMID	PMID:26859759	6	24	9606	MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	1.42e-11	8.29e-07	(2016) Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling.
PMID	PMID:24380850	6	24	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	1.42e-11	8.29e-07	(2014) Divergent gene expression responses to complicated grief and non-complicated grief.
PMID	PMID:17257431	8	99	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	1.61e-11	8.29e-07	(2007) Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
PMID	PMID:29947965	6	25	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	1.76e-11	8.8e-07	(2018) Of mice and men: the host response to influenza virus infection.
PMID	PMID:20709292	8	101	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,RNF213	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,RNF213	1.87e-11	9.24e-07	(2010) Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
PMID	PMID:32566414	6	26	9606	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,MX1	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,MX1	2.17e-11	1.06e-06	(2020) Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
PMID	PMID:30779786	6	26	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58	2.17e-11	1.06e-06	(2019) Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system.
PMID	PMID:32839612	7	58	9606	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,MX1	2.45e-11	1.16e-06	(2020) SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
PMID	PMID:23847613	7	58	9606	SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	SAMHD1,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	2.45e-11	1.16e-06	(2013) The Interferon-Signature of Sjoegrens Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.
PMID	PMID:18794103	7	60	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	3.05e-11	1.41e-06	(2008) Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
PMID	PMID:27018244	5	9	9606	MX2,OAS2,IFIT1,DDX58,MX1	MX2,OAS2,IFIT1,DDX58,MX1	3.09e-11	1.42e-06	(2016) Comparative transcriptome analyses indicate enhanced cellular protection against FMDV in PK15 cells pretreated with IFN-gamma.
PMID	PMID:32276512	6	28	9606	OAS3,OAS2,IFIT3,IFIT2,DDX58,MX1	OAS3,OAS2,IFIT3,IFIT2,DDX58,MX1	3.21e-11	1.45e-06	(2020) 2, 5-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Iota IFN Signaling Pathway.
PMID	PMID:28003963	6	28	9606	OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	3.21e-11	1.45e-06	(2017) Transcriptome analysis reveals common differential and global gene expression profiles in bluetongue virus serotype 16 (BTV-16) infected peripheral blood mononuclear cells (PBMCs) in sheep and goats.
PMID	PMID:34276695	6	29	9606	OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	3.87e-11	1.71e-06	(2021) PPE38-Secretion-Dependent Proteins of M. tuberculosis Alter NF-kB Signalling and Inflammatory Responses in Macrophages.
PMID	PMID:34724821	6	29	9606	OAS3,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,IFIT1,IFIT3,IFIT2,DDX58,MX1	3.87e-11	1.71e-06	(2021) Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression.
PMID	PMID:34997119	8	113	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1,HLA-B	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1,HLA-B	4.37e-11	1.89e-06	(2022) Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.
PMID	PMID:26116899	5	10	9606	MX2,IFIT1,IFIT3,IFIT2,MX1	MX2,IFIT1,IFIT3,IFIT2,MX1	4.64e-11	1.99e-06	(2015) Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells.
PMID	PMID:32162777	7	65	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	5.13e-11	2.18e-06	(2020) TLR4-dependent shaping of the wound site by MSCs accelerates wound healing.
PMID	PMID:30206152	7	65	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	5.13e-11	2.18e-06	(2018) Deconvolution of pro- and antiviral genomic responses in Zika virus-infected and bystander macrophages.
PMID	PMID:32529027	6	31	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,MX1	5.52e-11	2.29e-06	(2020) MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells.
PMID	PMID:34339406	7	66	9606	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	OAS3,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1	5.67e-11	2.33e-06	(2021) Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString.
PMID	PMID:18575461	7	66	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,IFIT2,DDX58,MX1	5.67e-11	2.33e-06	(2008) Interferon-inducible antiviral effectors.
PMID	PMID:32539747	6	32	9606	IFIT1,IFIT3,IFIT2,DDX58,MX1,PNPT1	IFIT1,IFIT3,IFIT2,DDX58,MX1,PNPT1	6.55e-11	2.64e-06	(2020) Dynamic rewiring of the human interactome by interferon signaling.
PMID	PMID:32616594	6	32	9606	MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	6.55e-11	2.64e-06	(2020) Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-lambda in vitro and in mice.
PMID	PMID:35358182	6	33	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,MX1	OAS3,SAMHD1,MX2,OAS2,IFIT1,MX1	7.73e-11	3.05e-06	(2022) Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
RCTM	HSA-909733	10	69	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,HLA-A,MX1,HLA-B	1.46e-16	3.18e-13	Interferon alpha/beta signaling
RCTM	HSA-913531	11	196	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,HLA-A,MX1,HLA-B	6.65e-14	7.22e-11	Interferon Signaling
RCTM	HSA-1169410	6	81	9606	OAS3,MX2,OAS2,IFIT1,DDX58,MX1	OAS3,MX2,OAS2,IFIT1,DDX58,MX1	1.12e-08	8.13e-06	Antiviral mechanism by IFN-stimulated genes
RCTM	HSA-168256	16	1956	9606	OAS3,CD97,NECTIN2,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3,RNF213	OAS3,CD97,PVRL2,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,TAP2,DDX58,HLA-A,MX1,HLA-B,LAMTOR3,RNF213	1.06e-07	4.62e-05	Immune System
RCTM	HSA-8983711	3	9	9606	OAS3,OAS2,DDX58	OAS3,OAS2,DDX58	1.24e-06	0.00045	OAS antiviral response
RCTM	HSA-1169408	4	73	9606	MX2,IFIT1,DDX58,MX1	MX2,IFIT1,DDX58,MX1	1.18e-05	0.0037	ISG15 antiviral mechanism
RCTM	HSA-983170	3	25	9606	TAP2,HLA-A,HLA-B	TAP2,HLA-A,HLA-B	1.81e-05	0.0049	Antigen Presentation: Folding, assembly and peptide loading of class I MHC
RCTM	HSA-877300	4	88	9606	OAS3,OAS2,HLA-A,HLA-B	OAS3,OAS2,HLA-A,HLA-B	2.39e-05	0.0058	Interferon gamma signaling
WikiPathways	WP4197	3	23	9606	IFIT1,IFIT3,MX1	IFIT1,IFIT3,MX1	1.44e-05	0.0097	Immune response to tuberculosis
WikiPathways	WP4868	3	31	9606	OAS3,OAS2,DDX58	OAS3,OAS2,DDX58	3.27e-05	0.0111	Type I interferon induction and signaling during SARS-CoV-2 infection
WikiPathways	WP4880	3	33	9606	OAS3,OAS2,DDX58	OAS3,OAS2,DDX58	3.9e-05	0.0111	Host-pathogen interaction of human coronaviruses - interferon induction
WikiPathways	WP5039	3	66	9606	IFIT2,DDX58,MX1	IFIT2,DDX58,MX1	0.00027	0.0465	SARS-CoV-2 innate immunity evasion and cell-specific immune response
NetworkNeighborAL	CL:19379	10	83	9606	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,RNF213	OAS3,SAMHD1,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,RNF213	8.07e-16	3.67e-12	Mixed, incl. interferon alpha/beta signaling, and negative regulation of type i interferon production
NetworkNeighborAL	CL:19385	9	61	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,RNF213	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,MX1,RNF213	4.83e-15	1.1e-11	Interferon alpha/beta signaling, and Negative regulators of DDX58/IFIH1 signaling
NetworkNeighborAL	CL:19397	7	16	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1	9.09e-15	1.38e-11	Microphthalmia with limb anomalies, and Interferon alpha/beta signaling
NetworkNeighborAL	CL:19389	8	42	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,RNF213	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,MX1,RNF213	2.85e-14	2.16e-11	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19399	6	11	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2	3.02e-13	1.71e-10	Mixed, incl. 2-5-oligoadenylate synthetase activity, and nephropathia epidemica
NetworkNeighborAL	CL:19402	4	5	9606	OAS2,IFIT1,IFIT3,IFIT2	OAS2,IFIT1,IFIT3,IFIT2	1.2e-09	5.45e-07	Mixed, incl. 4fe-4s single cluster domain, and interferon-induced protein with tetratricopeptide repeats 3
NetworkNeighborAL	CL:19090	5	44	9606	NECTIN2,TAP2,HLA-A,HLA-B,SPART	PVRL2,TAP2,HLA-A,HLA-B,SPG20	2.81e-08	1.16e-05	Mixed, incl. class i histocompatibility antigen, domains alpha 1 and 2, and antigen processing and presentation
NetworkNeighborAL	CL:19092	3	18	9606	TAP2,HLA-A,HLA-B	TAP2,HLA-A,HLA-B	7.4e-06	0.0022	Mixed, incl. tap binding, and mhc class i protein complex binding
